Clinical trial
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in…
NCT00435955 · Azienda Ospedaliera San Giovanni Battista, Other · Unknown status
Key facts
| NCT number | NCT00435955 |
|---|---|
| Title | Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma |
| Official title | MULTICENTER RANDOMIZED PROGRAM COMPARING HIGH-DOSE CHEMOTHERAPY + RITUXIMAB AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) AUTOGRAFT vs. CHOP + RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA |
| Lead sponsor | Azienda Ospedaliera San Giovanni Battista, Other |
| Collaborators | University of Turin, Italy Gruppo Italiano Trapianto di Midollo Osseo Gruppo Italiano Studio Linfomi Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Follicular Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | High dose chemotherapy with autologous transplantation, Rituximab |
| Enrollment | 240 |
| Start date | Mar 1, 2000 |
| First posted | Feb 16, 2007 |
| Last update posted | Feb 16, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: